Figures & data
Table 1. Research and review articles published in 2010.
Table 2. Editorial board recommendations for best article.
MacNeill
, R Sangster T, Moussallie M, Trinh V, Stromeyer R, Daley E. Stable-labeled analogues and reliable quantification of nonprotein biomarkers by LC–MS/MS. Bioanalysis2(1), 69–80 (2010).
Sun J
, SchnackenbergLK, HansenDK, BegerRD. Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC–MS-based metabolomics. Bioanalysis2(2), 207–216 (2010).
Andree U
, Mueller-SeitzE, UsaiIet al. Tetracycline sensing using novel doxycycline derivatives immobilized on different surface plasmon resonance biosensor surfaces. Bioanalysis2(2), 217–227 (2010).
Thomas DP
, FoleyJP. Detection of prohibited substances in equestrian sport through direct injection of equine serum using micellar LC. Bioanalysis2(2), 229–235 (2010).
Dueker SR
, LohstrohPN, GiacomoJA, VuongLT, KeckBD, VogelJS. Early human ADME using microdoses and microtracers: bioanalytical considerations. Bioanalysis2(3), 441–454 (2010).
Bautista AC
, WullnerD, MoxnessM, SwansonSJ, ChirmuleN, JawaV. Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment. Bioanalysis3(4), 721–731 (2010).
Goodison S
, SunY, UrquidiV. Derivation of cancer diagnostic and prognostic signatures from gene expression data. Bioanalysis2(5), 855–862 (2010).
Mulvana DE
. Critical topics in ensuring data quality in bioanalytical LC–MS method development. Bioanalysis2(6), 1051–1072 (2010).
Mitrea N
, LeBlancA, St-OngeM, SlenoL. Assessing covalent binding of reactive drug metabolites by complete protein digestion and LC–MS analysis. Bioanalysis3(7), 1211–1221 (2010).
Prince PJ
, MatsudaKC, RetterMW, ScottG. Assessment of DBS technology for the detection of therapeutic antibodies. Bioanalysis3(8), 1449–1460 (2010).
Wu DY
, Patti-DiazL, HillCG. Development and validation of flow cytometry methods for pharmacodynamic clinical biomarkers. Bioanalysis3(9), 1617–1626 (2010).
Islam KN
, IharaM, DongJ, KasagiN, MoriT, UedaH. Micro open-sandwich ELISA to rapidly evaluate thyroid hormone concentration from serum samples. Bioanalysis3(10), 1683–1687 (2010).
Blessborn D
, RomsingS, BergqvistY, LindegardhN. Assay for screening for six antimalarial drugs and one metabolite using dried blood spot sampling, sequential extraction and ion-trap detection. Bioanalysis2(11), 1839–1847 (2010).
Butterfield AM
, ChainJS, AckermannBL, KonradRJ. Comparison of assay formats for drug-tolerant immunogenicity testing. Bioanalysis2(12), 1961–1969 (2010).
Emmons G
, RowlandM. Pharmacokinetic considerations as to when to use dried blood spot sampling. Bioanalysis2(11), 1791–1796 (2010).
Szapacs ME
, UrbanskiJJ, KehlerJR. Absolute quantification of a therapeutic domain antibody using ultra-performance liquid chromatography–mass spectrometry and immunoassay. Bioanalysis2(9), 1597–1608 (2010).
Varma D
, JansenSA, GantiS. Chromatography with higher pressure, smaller particles and higher temperature: a bioanalytical perspective. Bioanalysis2(12), 2019–2034 (2010).
Spooner N
, RamakrishnanY, BarfieldM, DewitO, MillerS. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Bioanalysis2(8), 1515–1522 (2010).
Smith DA
. Does validation stagnate innovation? Bioanalysis2(8), 1349–1350 (2010).
Lahaie M
, Mess J-N, Furtado M, Garofolo F. Elimination of LC–MS/MS matrix effect due to phospholipids using specific solid-phase extraction elution conditions. Bioanalysis2(6), 1011–1021 (2010).
Gao H
, WilliamsJ, CarrierS, BrummelCL. Bioanalytical solutions to acetonitrile shortages. Bioanalysis2(9), 1627–1640 (2010).
Ni J
, OuyangH, SetoCet al. Sensitivity and proportionality assessment of metabolites from microdose to high dose in rats using LC–MS/MS. Bioanalysis2(3), 407–419 (2010).
Timmerman P
, LowesS, FastDM, GarofoloF. Request for Global Harmonization of the Guidance for Bioanalytical Method Validation and Sample Analysis. Bioanalysis2(4), 683 (2011).
Osiri JK
, ShadpourH. Toward point-of-care microchip profiling of proteins. Bioanalysis2(10), 1745–1754 (2010).
Savoie N
, GarofoloF, van Amsterdam Pet al. 2010 White Paper on recent issues in regulated bioanalysis and global harmonization of bioanalytical guidance. Bioanalysis2(12), 1945–1960 (2010).
Timmerman P
, KallMA, GordonBet al. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum. Bioanalysis2(7), 1185–1194 (2010).
Kuang B
, KingL, WangHF. Therapeutic monoclonal antibody concentration monitoring: free or total? Bioanalysis2(6), 1125–1140 (2010).